Primary Hyperoxaluria Type 2
3 clinical trials · Condition
◉ Watch Primary Hyperoxaluria Type 2
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 (NCT06465472) | Biocodex | 2024-08-01 |
| Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function (NCT05001269) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2022-02-22 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
Track Primary Hyperoxaluria Type 2 automatically
Every clearance here is in the API, with alerts when new ones post.